» Articles » PMID: 38260048

Feasibility and Safety of Combined Laparoscopic and Transvaginal Oocyte Retrieval in a Woman with Vaginal Recurrence of Cervical Adenocarcinoma: a Case Report

Overview
Date 2024 Jan 23
PMID 38260048
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Oocyte cryopreservation is an established technique for fertility preservation in women diagnosed with cancer. However, some clinical scenarios may preclude the commonly used transvaginal approach to oocyte retrieval. In such cases, a laparoscopic approach may be required. Here, we report the feasibility and safety of a combined laparoscopic and transvaginal approach for oocyte retrieval in a woman with vaginal recurrence of cervical adenocarcinoma. This approach allowed for oocyte cryopreservation prior to cancer treatment, representing a novel application in this clinical context.

Methods: A 31-year-old woman with endocervical adenocarcinoma underwent laparoscopic radical hysterectomy and pelvic lymph node dissection. She presented with vaginal recurrence and was referred for fertility preservation by oocyte cryopreservation before chemotherapy and radiotherapy/brachytherapy. Ovarian stimulation was initiated with a gonadotropin antagonist protocol combined with aromatase inhibitors, and oocyte retrieval was performed with a combined laparoscopic and transvaginal approach.

Results: A total of 18 oocytes were retrieved and 10 mature oocytes were cryopreserved. Peritoneal fluid cytology was negative for malignancy. The patient underwent chemotherapy and radiotherapy/brachytherapy and was disease-free after oocyte retrieval.

Conclusion: The combined laparoscopic and transvaginal approach for oocyte retrieval emerges as a practical and efficacious method for fertility preservation in cases of cervical adenocarcinoma with vaginal recurrence. Further comprehensive studies are warranted to establish the reproducibility, safety, and long-term outcomes associated with this innovative approach.

References
1.
Turan V, Gayete-Lafuente S, Bang H, Oktay K . Outcomes of random-start letrozole protocol with PGT-A in women with breast cancer undergoing fertility preservation. J Assist Reprod Genet. 2023; 40(10):2401-2408. PMC: 10504207. DOI: 10.1007/s10815-023-02882-0. View

2.
Zhou F, Tang X, Shao Z, Chen X, Gao W, Fang C . Radical surgery for stage IB2/IIA2 cervical cancer: A large retrospective study. Front Oncol. 2022; 12:948298. PMC: 9541141. DOI: 10.3389/fonc.2022.948298. View

3.
Deutinger J, Reinthaller A, Csaicsich P, Riss P, Fischl F, Bernaschek G . Follicular aspiration for in vitro fertilization: sonographically guided transvaginal versus laparoscopic approach. Eur J Obstet Gynecol Reprod Biol. 1987; 26(2):127-33. DOI: 10.1016/0028-2243(87)90047-5. View

4.
Martinez F . Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives. Hum Reprod. 2017; 32(9):1802-1811. PMC: 5850800. DOI: 10.1093/humrep/dex218. View

5.
Zighelboim I, Wright J, Gao F, Case A, Massad L, Mutch D . Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer. Gynecol Oncol. 2013; 130(1):64-8. PMC: 3870479. DOI: 10.1016/j.ygyno.2013.04.009. View